alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-L-Fucp

Term ID

CHEBI:148780

Synonyms

(3S,4S,5S,6S)-5-[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxane-2,3,4-triol
alpha-D-galacto-hexopyranosyl-(1->4)-beta-D-galacto-hexopyranosyl-(1->4)-6-deoxy-L-galacto-hexopyranose
alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-6-deoxy-L-galactopyranose
alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-L-fucopyranose
Gal(a1-4)Gal(b1-4)Fuc

Definition

A trisaccharide consisting of α-D-galactopyranose, β-D-galactopyranose and L-fucopyranose residues joined in sequence by (1→4) glycosidic bonds.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-L-Fucp

Phenotype where environments contain alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-L-Fucp

Phenotype modified by environments containing alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-L-Fucp

Phenotype affecting alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-L-Fucp

Human Disease Model